| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -115.8% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 4.9 | n/a |
| Pr/Book | 1.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -22.6% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 0.39 | (2.38) | (2.90)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 1.26 | (2.92) | (13.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 1.82 | (3.71) | (13.90)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 3.78 | (2.90) | (11.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 2.92 | (3.73) | (12.60)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Expansion of Senior Finance Leadership Team | 24-Nov-2025 | 07:00 | RNS |
| Interim Results and Investor Presentation | 30-Sep-2025 | 07:00 | RNS |
| Asset Purchase Agreement with Destiny Pharma | 22-Sep-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 52.00p |
| Change Today | 0.90p |
| % Change | 1.76 % |
| 52 Week High | 56.50 |
| 52 Week Low | 36.50 |
| Volume | 24,559 |
| Shares Issued | 27.77m |
| Market Cap | £14.44m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:07 | 6,242 @ 51.33p |
| 14:37 | 3,000 @ 51.33p |
| 14:36 | 2,000 @ 51.33p |
| 13:17 | 9,434 @ 51.33p |
| 12:35 | 1,197 @ 53.00p |
You are here: research